Brief: Zymeworks Q3 Adjusted EPS USD -0.38 Vs. IBES Estimate USD -0.47
07/11/2023 21:05
Nov 07 (Reuters) - Zymeworks Q3 pretax profit USD -27.577 million. * Q3 income from operations USD -33.237 million * Q3 operating expenses USD 49.743 million * Q3 basic EPS USD -0.41
Recent news on Zymeworks
See all newsUS STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug